Infection management in solid organ transplantation poses unique challenges, with a diverse array of potential pathogens and associated antimicrobial therapies. With limited high-quality randomized clinical trials to direct optimal care, therapeutic "myths" may propagate and contribute to suboptimal or excessive antimicrobial use. We discuss 6 therapeutic myths with particular relevance to solid organ transplantation and provide recommendations for infectious diseases clinicians involved in the care of this high-risk population.
Keywords: BK virus; asymptomatic bacteriuria; dental prophylaxis; ganciclovir; trimethoprim-sulfamethoxazole; vaccination.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.